The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Microparticles in the blood of patients with systemic lupus erythematosus (SLE): phenotypic characterization and clinical associations
Open accessAbstract
Systemic lupus erythematosus (SLE) is a prototypic autoimmune disease characterized by circulating autoantibodies and the formation of immune complexes. In these responses, the selecting self-antigens likely derive from the remains of dead and dying cells, as well as from disturbances in clearance. During cell death/activation, microparticles (MPs) can be released to the circulation. Previous MP studies in SLE have been limited in size and differ regarding numbers and phenotypes. Therefore, to characterize MPs more completely, we investigated 280 SLE patients and 280 individually matched controls. MPs were measured with flow cytometry and phenotyped according to phosphatidylserine expression (PS+/PS−), cellular origin and inflammatory markers. MPs, regardless of phenotype, are 2–10 times more abundant in SLE blood compared to controls. PS− MPs predominated in SLE, but not in controls (66% vs. 42%). Selectively in SLE, PS− MPs were more numerous in females and smokers. MP numbers decreased with declining renal function, but no clear association with disease activity was observed. The striking abundance of MPs, especially PS− MPs, suggests a generalized disturbance in SLE. MPs may be regarded as “liquid biopsies” to assess the production and clearance of dead, dying and activated cells, i.e. pivotal events for SLE pathogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Moreover, patients with higher disease activity have notably higher numbers of extracellular vesicle-containing immune complexes with exposed mitochondrial outer membrane markers, TOMM-20 and hexokinase I218, than patients with lower disease activity, suggesting that proteins of mitochondrial origin could be potential autoantigens in SLE217.”
From The role of mitochondria in rheumatic diseases (2022) · cites this paper as [217]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The plasma of patients with SLE contains elevated levels of extracellular vesicle-containing immune complexes compared with healthy individuals, the presence of which is associated with anti-dsDNA antibodies, pro-inflammatory cytokines and disease activity213–217.”
From The role of mitochondria in rheumatic diseases (2022) · cites this paper as [217]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The 1982 revised criteria for the classification of systemic lupus erythematosus
Tan, E. M., Cohen, A. S., Fries, J. F., Masi, A. T., Mcshane, D. J., Rothfield, N. F., Schaller, J. G., Talal, N., & Winchester, R. J. (1982) · Arthritis & Rheumatism · doi:10.1002/art.1780251101 · Cited by 14,519
MIYAKIS, S., LOCKSHIN, M. D., ATSUMI, T., BRANCH, D. W., BREY, R. L., CERVERA, R., DERKSEN, R. H. W. M., DE GROOT, P. G., KOIKE, T., MERONI, P. L., et al. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2006.01753.x · Cited by 7,203
CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells
Henn, V., Slupsky, J. R., Gräfe, M., Anagnostopoulos, I., Förster, R., Müller-Berghaus, G., & Kroczek, R. A. (1998) · Nature · doi:10.1038/35393 · Cited by 2,078
Microparticles in Hemostasis and Thrombosis
Owens, A. P., & Mackman, N. (2011) · Circulation Research · doi:10.1161/circresaha.110.233056 · Cited by 835
Lisnevskaia, L., Murphy, G., & Isenberg, D. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60128-8 · Cited by 752
Schiraldi, M., Raucci, A., Muñoz, L. M., Livoti, E., Celona, B., Venereau, E., Apuzzo, T., De Marchis, F., Pedotti, M., Bachi, A., et al. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20111739 · Cited by 676
The role of defective clearance of apoptotic cells in systemic autoimmunity
Muñoz, L. E., Lauber, K., Schiller, M., Manfredi, A. A., & Herrmann, M. (2010) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2010.46 · Cited by 627
Digestion of Chromatin in Apoptotic Cell Microparticles Prevents Autoimmunity
Sisirak, V., Sally, B., D’Agati, V., Martinez-Ortiz, W., Özçakar, Z. B., David, J., Rashidfarrokhi, A., Yeste, A., Panea, C., Chida, A. S., et al. (2016) · Cell · doi:10.1016/j.cell.2016.05.034 · Cited by 450
LACROIX, R., ROBERT, S., PONCELET, P., KASTHURI, R. S., KEY, N. S., & DIGNAT‐GEORGE, F. (2010) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2010.04047.x · Cited by 351
The role of microparticles in the pathogenesis of rheumatic diseases
Beyer, C., & Pisetsky, D. S. (2010) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2009.229 · Cited by 324
Self-citation
Cited by
Cell-Free DNA as a Biomarker in Autoimmune Rheumatic Diseases
Duvvuri, B., & Lood, C. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00502 · Cited by 282
“MPs, in particular if released from activated platelets, could also be the source of cf-mtDNA (57, 59, 60).”
BackgroundPlatelet Extracellular Vesicles: Beyond the Blood
Puhm, F., Boilard, E., & Machlus, K. R. (2021) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.120.314644 · Cited by 250
Platelet-derived extracellular vesicles infiltrate and modify the bone marrow during inflammation
French, S. L., Butov, K. R., Allaeys, I., Canas, J., Morad, G., Davenport, P. E., Laroche, A., Trubina, N. M., Italiano, J. E., Moses, M. A., et al. (2020) · Blood Advances · doi:10.1182/bloodadvances.2020001758 · Cited by 118
Ortega, A., Martínez-Arroyo, O., Forner, M. J., & Cortés, R. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics13010003 · Cited by 117
“Additionally, a deeper phenotypic analysis of MP from SLE showed that MP were more abundant in these patients and were associated with declining renal function [80].”
BackgroundGlobal requirements for manufacturing and validation of clinical grade extracellular vesicles
Thakur, A., & Rai, D. (2024) · The Journal of Liquid Biopsy · doi:10.1016/j.jlb.2024.100278 · Cited by 132
“Thus, extracting and modifying them for therapeutic purposes can be achieved easily [111 – 116].”
Metadata
- Authors
- Mobarrez, F., Vikerfors, A., Gustafsson, J. T., Gunnarsson, I., Zickert, A., Larsson, A., Pisetsky, D. S., Wallén, H., & Svenungsson, E.
- Affiliations
- Karolinska University Hospital (SE)
- Uppsala University Hospital (SE)
- Duke Medical Center (US)
- Danderyds sjukhus (SE)
- Corresponding author
- Mobarrez, Fariborz
- ORCID
- Venue
- Scientific Reports
- Published
- 2016-10-25
- Volume
- 6
- Issue
- 1
- Pages
- 36025-36025
- ISSN
- 2045-2322 (ISSN-L)
- PMC
- PMC5078765
- OpenAlex
- W2534182712
- Cited by
- 85
- References
- 56
- Citations by year
- 2026: 4 · 2025: 2 · 2024: 6 · 2023: 9 · 2022: 11 · 2021: 11 · 2020: 14 · 2019: 15 · 2018: 8 · 2017: 5
- FWCI
- 9.93
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Scientific Reports (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Uppsala University Publications (Uppsala University) (submittedVersion, other-oa)
- Funders
- Hjärt-Lungfonden
- Karolinska Institutet
- Stockholms Läns Landsting
- Vetenskapsrådet
- Svenska Läkaresällskapet
- Reumatikerförbundet
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Life Sciences › Immunology and Microbiology › Immunology › Phagocytosis and Immune Regulation
- Keywords
- systemic lupus erythematosus, microparticles, phosphatidylserine, cell death, immune complexes, autoantibodies, liquid biopsy, renal function, disease activity, smoking, sex differences
- MeSH terms
- Antigen-Antibody Complex, Autoantibodies, Autoantigens, Blood Platelets, Cross-Sectional Studies, Female, Flow Cytometry, Humans, Lupus Erythematosus, Systemic, Male, Middle Aged, Thromboplastin, Biomarkers, Vascular Cell Adhesion Molecule-1, CD40 Ligand, HMGB1 Protein, Cell-Derived Microparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Microparticles in the blood of patients with systemic lupus erythematosus (SLE): phenotypic characterization and clinical associations. https://app.cochat.ai/papers/10.1038/srep36025
- The paper
- Mobarrez, F., Vikerfors, A., Gustafsson, J. T., Gunnarsson, I., Zickert, A., Larsson, A., Pisetsky, D. S., Wallén, H., & Svenungsson, E. (2016). Microparticles in the blood of patients with systemic lupus erythematosus (SLE): phenotypic characterization and clinical associations. Scientific Reports. https://doi.org/10.1038/srep36025
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.